Unnamed: 0,title,date,stock,sentiment
953763.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,OMCL,negative
953764.0,"Benchmark Maintains Buy on Omnicell, Lowers Price Target to $82",2020-05-08 08:09:00-04:00,OMCL,negative
953765.0,"Omnicell Q1 EPS $0.660 Beats $0.530 Estimate, Sales $229.700M Beat $219.410M Estimate",2020-05-07 16:10:00-04:00,OMCL,neutral
953766.0,"Omnicell Q4 EPS $0.77 Misses $0.78 Estimate, Sales $248.292M Beat $243.69M Estimate",2020-02-06 16:03:00-05:00,OMCL,negative
953767.0,"Wells Fargo Maintains Equal-Weight on Omnicell, Raises Price Target to $85",2020-01-08 10:53:00-05:00,OMCL,positive
953768.0,"Cantor Fitzgerald Maintains Overweight on Omnicell, Raises Price Target to $95",2019-12-11 09:13:00-05:00,OMCL,negative
953769.0,"Omnicell Sees Q4 Adj. EPS $0.75-$0.80 vs $0.79 Est., Sees FY19 Adj. EPS $2.79-$2.84 vs $2.78 Est.",2019-10-24 16:04:00-04:00,OMCL,neutral
953770.0,"Omnicell Q3 Adj. EPS $0.76 Beats $0.71 Estimate, Sales $228.8M Miss $231.86M Estimate",2019-10-24 16:03:00-04:00,OMCL,negative
953771.0,Omnicell shares are trading higher after the company reported Q2 EPS and sales up from last year.,2019-07-26 09:42:00-04:00,OMCL,positive
953772.0,"Craig-Hallum Upgrades Omnicell to Buy, Announces $85 Price Target",2019-07-26 07:28:00-04:00,OMCL,neutral
953773.0,36 Technology Stocks Moving In Thursday's After-Market Session,2019-07-26 04:53:00-04:00,OMCL,neutral
953774.0,"Omnicell Sees FY19 Adj. EPS $2.65-$2.82 vs $2.76 Estimate, Sales $886M-$900M vs $891.95M Est.",2019-07-25 16:36:00-04:00,OMCL,neutral
953775.0,"Omnicell Sees Q3 Adj. EPS $0.67-$0.72 vs $0.72 Estimate, Sales $227M-$233M vs $232.2M Est.",2019-07-25 16:36:00-04:00,OMCL,neutral
953776.0,"Omnicell Q2 EPS $0.67 Up From $0.46 YoY, Sales $217.413M Up From $188.673M YoY",2019-07-25 16:35:00-04:00,OMCL,neutral
953777.0,Omnicell Reports Partnership With Atrium,2019-07-19 08:06:00-04:00,OMCL,neutral
953778.0,52 Biggest Movers From Yesterday,2019-07-16 05:15:00-04:00,OMCL,neutral
953779.0,"Omnicell Reports Formalized Long-Term Partnership With Northern Arizona Healthcare To Digitize, Automate Medication Mgmt. Processes",2019-07-15 16:01:00-04:00,OMCL,neutral
953780.0,Omnicell shares are trading higher after the company responded to a report issued by GlassHouse Research.,2019-07-15 13:45:00-04:00,OMCL,positive
953781.0,Omnicell Responds to Short-Seller Report,2019-07-15 08:04:00-04:00,OMCL,neutral
953782.0,40 Biggest Movers From Friday,2019-07-15 05:47:00-04:00,OMCL,neutral
953783.0,36 Stocks Moving In Friday's Mid-Day Session,2019-07-12 12:38:00-04:00,OMCL,neutral
953784.0,"Omnicell shares are trading lower, potentially on continued weakness following a negative Thursday research report from GlassHouse Research.",2019-07-12 12:04:00-04:00,OMCL,negative
953785.0,55 Biggest Movers From Yesterday,2019-07-12 05:18:00-04:00,OMCL,neutral
953786.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-07-11 12:50:00-04:00,OMCL,neutral
953787.0,Omnicell shares trading lower following negative research report from GlassHouse Research.,2019-07-11 12:46:00-04:00,OMCL,negative
953788.0,Short Seller Accuses Omnicell Of 'Accounting Gimmicks',2019-07-11 10:14:00-04:00,OMCL,negative
953789.0,UPDATE: GlassHouse Research Issues 'Ominous Omnicell (OMCL) Delays the Inevitable',2019-07-11 10:02:00-04:00,OMCL,negative
953790.0,"Omnicell Shares Fall To Session Low, Down 5%",2019-07-11 10:01:00-04:00,OMCL,neutral
953791.0,"GlassHouse Research Issues Negative Report On Omnicell, Sets $35.50 Price Target; Shares Had Been Down ~3.5% Prior To Release Of Report",2019-07-11 10:00:00-04:00,OMCL,negative
953792.0,"Craig-Hallum Downgrades Omnicell, Inc. - Common Stock to Hold",2019-04-26 08:06:00-04:00,OMCL,neutral
953793.0,Omnicell shares are trading higher after the company reported better-than-expected Q1 EPS and sales issued Q2 and FY19 guidance above the consensus estimates.,2019-04-25 17:07:00-04:00,OMCL,positive
953794.0,"Omnicell Sees Q2 Adj. EPS $0.61-$0.66 vs $0.56 Est., Sales $211M-$217M vs $212.74M Est., Sees FY19 EPS $2.62-$2.82 vs $2.51 Est., Sales $880M-$900M vs $890.22M Est.",2019-04-25 16:50:00-04:00,OMCL,neutral
953795.0,"Omnicell Q1 Adj. EPS $0.61 Beats $0.41 Estimate, Sales $202.5M Beat $199.72M Estimate",2019-04-25 16:47:00-04:00,OMCL,neutral
953796.0,The University Of Tennessee Medical Center Selects Omnicell Solutions To Support Medication Management Strategy,2019-04-24 16:35:00-04:00,OMCL,positive
953797.0,"Shares of several healthcare-related stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'.",2019-04-23 14:30:00-04:00,OMCL,positive
953798.0,"Omnicell Reports Inova Extended Partnership With Co. For Medication Dispensing Cabinet Automation, IV Compounding Solutions",2019-04-22 08:12:00-04:00,OMCL,positive
953799.0,Shares of several healthcare companies are trading lower on continued weakness over concerns of 'Medicare for all' support within 2020 presidential candidates and the uncertainty over healthcare policy going into the election.,2019-04-18 10:42:00-04:00,OMCL,negative
953800.0,Shares of several healthcare companies are trading lower after Trump renewed his efforts to repeal and replace the Affordable Care Act; the Department of Justice moved to accelerate the appeal process in hopes to invalidate the ACA as unconstitutional.,2019-04-17 10:38:00-04:00,OMCL,positive
953801.0,"The Daily Biotech Pulse: BioMarin Slips On Earnings, TherapeuticsMD Posts In-Line Results, Orchard To Present Immunodeficiency Drug Data",2019-02-22 08:50:00-05:00,OMCL,neutral
953802.0,66 Biggest Movers From Friday,2019-02-11 04:33:00-05:00,OMCL,neutral
953803.0,48 Stocks Moving In Friday's Mid-Day Session,2019-02-08 12:42:00-05:00,OMCL,neutral
953804.0,Omnicell shares are trading higher after the company provided reported Q4 EPS and sales above last year's figures; the company also issued FY19 sales guidance above estimates.,2019-02-08 12:02:00-05:00,OMCL,positive
953805.0,"Omnicell Sees Q1 Adj. EPS $0.38-$0.43 vs $0.39 Est., Adj. Sales $196M-$202M vs $202.28M Est.; Sees FY19 Adj. EPS $2.40-$2.60 vs $2.42 Est., Sales $880M-$900M vs $876.4M Est.",2019-02-07 16:44:00-05:00,OMCL,neutral
953806.0,"Omnicell Q4 EPS $0.70 Up From $0.55 YoY, Sales $211.8M Up From $198.257M YoY",2019-02-07 16:42:00-05:00,OMCL,neutral
953807.0,Pivotal Updates Ad Agencies Ahead of Q4 Earnings,2019-01-07 16:05:00-05:00,OMCL,neutral
953808.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018",2018-12-04 09:20:00-05:00,OMCL,neutral
953809.0,"Stocks Which Set New 52-Week High Yesterday, Thurs., Nov. 29, 2018",2018-11-30 10:25:00-05:00,OMCL,neutral
953810.0,"Stocks Which Set New 52-Week High Yesterday, Wed., Nov. 7, 2018",2018-11-08 10:52:00-05:00,OMCL,neutral
953811.0,"Oppenheimer Maintains Outperform on Omnicell, Raises Price Target to $73",2018-10-26 11:48:00-04:00,OMCL,neutral
953812.0,"Omnicell Sees FY18 Adj. EPS $2-$2.05 vs $2 Estimate, Sales $787M-$793M vs $791.4M Est.",2018-10-25 16:42:00-04:00,OMCL,neutral
953813.0,"Omnicell Sees Q4 Adj. EPS $0.64-$0.69 vs $0.68 Estimate, Sales $211M-$217M vs $216.6M Est.",2018-10-25 16:42:00-04:00,OMCL,neutral
953814.0,"Omnicell, Inc. Q3 EPS $0.63 Beats $0.56 Estimate, Sales $204.267M Beat $203.48M Estimate",2018-10-25 16:41:00-04:00,OMCL,neutral
953815.0,"Stocks That Made New 52-Week Highs Yesterday, September 6th",2018-09-07 16:47:00-04:00,OMCL,neutral
953816.0,"Stocks Which Set New 52-Week High Yesterday, September 5th",2018-09-06 08:48:00-04:00,OMCL,neutral
953817.0,"Stocks Which Set New 52-Week High Yesterday, September 4th",2018-09-05 10:22:00-04:00,OMCL,neutral
953818.0,"Stocks Which Set New 52-Week High Yesterday, August 30th",2018-08-31 10:11:00-04:00,OMCL,neutral
953819.0,"Stocks Which Set New 52-Week High Friday, August 24th",2018-08-27 09:24:00-04:00,OMCL,neutral
953820.0,"Stocks Which Set New 52-Week High Yesterday, August 23rd",2018-08-24 09:11:00-04:00,OMCL,neutral
953821.0,"Stocks Which Set New 52-Week High Yesterday, August 22nd",2018-08-23 10:51:00-04:00,OMCL,neutral
953822.0,"Stocks Which Set New 52-Week High Yesterday, August 21st",2018-08-22 09:06:00-04:00,OMCL,neutral
953823.0,"Stocks Which Set New 52-Week High Tues., Aug. 21, 2018",2018-08-21 14:50:00-04:00,OMCL,neutral
953824.0,"Stocks Which Set New 52-Week High Yesterday, August 9th",2018-08-10 10:03:00-04:00,OMCL,neutral
953825.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,OMCL,neutral
953826.0,Beaumont Health Selects Omnicell's Medication Management Platform And Services To Support Improved Financial And Clinical Performance,2018-08-02 08:33:00-04:00,OMCL,positive
953827.0,"Stocks Which Set New 52-Week High Friday, July 27th",2018-07-30 12:05:00-04:00,OMCL,neutral
953828.0,62 Biggest Movers From Friday,2018-07-30 04:16:00-04:00,OMCL,neutral
953829.0,55 Stocks Moving In Friday's Mid-Day Session,2018-07-27 12:37:00-04:00,OMCL,neutral
953830.0,"Omnicell Shares Up 14.4% After Co. Late Thursday Reported Q2 Earnings Beat, Issued Inline Q3 Guidance; Craig-Hallum Upgraded To Buy Friday Morning",2018-07-27 10:38:00-04:00,OMCL,positive
953831.0,Craig-Hallum Upgrades Omnicell to Buy,2018-07-27 09:59:00-04:00,OMCL,neutral
953832.0,"Omnicell Sees FY18 Adj. EPS $1.90-$2.05 vs $1.95 Est., Sales $780M-$800M vs $790.27M Est.",2018-07-26 16:11:00-04:00,OMCL,neutral
953833.0,"Omnicell Sees Q3 Adj. EPS $0.52-$0.57 vs $0.56 Est., Sales $200M-$206M vs $202.68M Est.",2018-07-26 16:10:00-04:00,OMCL,neutral
953834.0,"Omnicell Q2 Adj. EPS $0.46 Beats $0.39 Estimate, Sales $189M Beat $188.77M Estimate",2018-07-26 16:09:00-04:00,OMCL,neutral
953835.0,"Omnicell Reports Expansion Of Strategic Partnership With NYU Langone Health For Addition Of Co.'s XT Automated Medication Dispensing Cabinets, XT Controlled Substance Manager In Facilities",2018-07-19 08:26:00-04:00,OMCL,neutral
953836.0,"Benchmark Assumes Omnicell at Buy, Announces Price Target $63",2018-06-29 09:22:00-04:00,OMCL,neutral
953837.0,"Omnicell Sees FY18 Adj. EPS $1.85-$2.05 vs $1.97 Est., Sales $780M-$800M vs $790.28M Est.",2018-04-26 16:42:00-04:00,OMCL,neutral
953838.0,"Omnicell Sees Q2 Adj. EPS $0.36-$0.42 vs $0.46 Est., Sales $185M-$190M vs $193.97M	Est.",2018-04-26 16:40:00-04:00,OMCL,neutral
953839.0,"Omnicell Q1 Adj. EPS $0.29 Beats $0.25 Est., Sales $182.62M Beats $177.37M Est.",2018-04-26 16:38:00-04:00,OMCL,neutral
953840.0,"Omnicell Sees Q1 Adj. EPS $0.22-$0.28, Adj. Sales $174M-$179M; FY18 Adj. EPS $1.85-$2.05, Adj. Sales $780M-$800M",2018-02-01 16:18:00-05:00,OMCL,neutral
953841.0,"Omnicell Reports Q4 Adj. EPS $0.54 vs $0.42 In Same Qtr. Last Year, Adj. Sales $198.3M vs $187.1M YoY",2018-02-01 16:17:00-05:00,OMCL,neutral
953842.0,Omnicell 8-K Shows Co. Raised Revolving Credit Facility From $200M To $315M,2017-12-26 16:08:00-05:00,OMCL,positive
953843.0,"Cantor Out Positive On Omnicell, Says Expanded UPMC Relationship Is A 'Significant' Endorsement of Co.'s New Product Strategy and Reiterates View That Co. Is Positioned Well To Sustain Top-Line Growth At Least Over Next Few Years",2017-12-20 10:25:00-05:00,OMCL,positive
953844.0,"The Week Ahead For December 4: The Biggest Catalysts, Conferences, And Investor Events",2017-12-04 11:23:00-05:00,OMCL,neutral
953845.0,"Omnicell Sees FY 2017 Adj. EPS $1.27 to $1.33 vs $1.30 Est., Sales $720M to $726M vs $733M Est.",2017-10-26 17:12:00-04:00,OMCL,neutral
953846.0,"Omnicell Sees Q4 Adj. EPS $0.49 to $0.55 vs $0.52 Est., Sales $201M to $207M vs $209M Est.",2017-10-26 17:11:00-04:00,OMCL,neutral
953847.0,"Omnicell Q3 Adj. EPS $0.42 vs $0.42 Est., Sales $186.78M vs $192.13M Est.",2017-10-26 17:10:00-04:00,OMCL,neutral
953848.0,Omnicell Receives Innovative Technology Designations from Vizient for IV Compounding Technology and XT Automated Dispensing System,2017-10-25 16:44:00-04:00,OMCL,positive
953849.0,Omnicell Reports Riverside Medical Center Selected Co.'s Medication Mgmt. Solutions,2017-10-25 08:10:00-04:00,OMCL,positive
953850.0,18 Biggest Mid-Day Gainers For Friday,2017-07-28 12:39:00-04:00,OMCL,neutral
953851.0,"Omnicell Sees Q3 Adj. EPS $0.38-$0.45 vs $0.45 Est., Sales $188M-$194M vs $197.37M Est.; FY17 Adj. EPS $1.22-$1.34 vs $1.28 Est., Sales $720M-$740M vs $729.64M Est.",2017-07-27 17:05:00-04:00,OMCL,neutral
953852.0,"Omnicell Reports Q2 Adj. EPS $0.31 vs $0.23 Est., Sales $180.9M vs $174.33M Est.",2017-07-27 17:04:00-04:00,OMCL,neutral
953853.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-06-13 08:10:00-04:00,OMCL,neutral
953855.0,Volume Spike in Omnicell,2017-06-05 09:55:00-04:00,OMCL,neutral
953856.0,"Omnicell Sees Q2 Adj. EPS $0.21-$0.27 vs $0.31 Est., Sales $172M-$178M vs $180.8M Est.",2017-05-04 08:02:00-04:00,OMCL,neutral
953857.0,"Omnicell Reports Q1 Adj. EPS $0.06 vs $0.02 Est., Sales $150.9M vs $152.4M Est.",2017-05-04 08:02:00-04:00,OMCL,neutral
953858.0,"Benzinga's Top Upgrades, Downgrades For April 21, 2017",2017-04-21 09:23:00-04:00,OMCL,positive
953859.0,PiperJaffray Downgrades Omnicell To Neutral,2017-04-21 06:41:00-04:00,OMCL,neutral
953860.0,"Omnicell Acquires InPharmics, Terms Not Disclosed",2017-04-19 08:02:00-04:00,OMCL,neutral
953861.0,"Oppenheimer Out Positive On Omnicell, Telling Investors To Buy on Weakness",2017-02-16 09:51:00-05:00,OMCL,positive
953862.0,"Earnings Scheduled For February 15, 2017",2017-02-15 04:45:00-05:00,OMCL,neutral
953863.0,"Dougherty Initiates Coverage On Omnicell At Buy, Announces $44 Price Target",2017-01-19 09:17:00-05:00,OMCL,neutral
953864.0,7 Biotech And Healthcare Picks For 2017 From Cantor Fitzgerald,2017-01-06 12:16:00-05:00,OMCL,neutral
953865.0,Omnicell Shares Down ~7% Midday After Closing 5.8% Lower Monday,2016-12-06 12:22:00-05:00,OMCL,neutral
953866.0,Omnicell Sees Revenue for H1 2017 Flat vs H1 2016,2016-12-06 06:08:00-05:00,OMCL,neutral
953867.0,Omnicell Investors Take Profits Over $36/Share Resistance Level Following ~12% Rally Over Last Month; Stock Down 6.6% During Monday's Intraday Session,2016-12-05 15:34:00-05:00,OMCL,positive
953868.0,Mid-Afternoon Market Update: NeuroDerm Surges Following Meeting With FDA; Cerecor Shares Slide,2016-12-05 14:21:00-05:00,OMCL,positive
953869.0,"Omnicell to Acquire Leading Pharmacy Provider Ateb, Inc.  For ~$41M",2016-11-29 08:01:00-05:00,OMCL,neutral
953870.0,Omnicell Re-Confirms FY16 Guidance Of $700-$710M vs. Est. $711M,2016-10-27 16:04:00-04:00,OMCL,neutral
953871.0,"Omnicell Reports Q3 EPS $0.38 vs. Est. $0.41, Rev. $179M vs. Est. $179M",2016-10-27 16:03:00-04:00,OMCL,neutral
953872.0,Sidoti & Co. Downgrades Omnicell to Neutral,2016-09-08 10:32:00-04:00,OMCL,neutral
953873.0,8-K from Omnicell Shows $50M Buyback Plan,2016-08-05 16:08:00-04:00,OMCL,neutral
953874.0,"Omnicell Sees FY16 Adj. EPS $1.50-$1.60 vs $1.56 Est., Sales at the Higher End of $695M-$715M vs $706.8M Est.",2016-07-28 16:05:00-04:00,OMCL,neutral
953875.0,"Omnicell Sees Q3 Adj. EPS $0.38-$0.42 vs $0.40 Est., Sales $176M-$183M vs $178.4M Est.",2016-07-28 16:04:00-04:00,OMCL,neutral
953876.0,"Omnicell Reports Q2 Adj. EPS $0.38 vs $0.32 Est., Sales $175.6M vs $170.9M Est.",2016-07-28 16:04:00-04:00,OMCL,neutral
953877.0,"Omnicell Sees Q2 Rev. $168-$175M vs. Est. $168M, EPS $0.30-$0.34 vs. Est. $0.36",2016-04-28 16:26:00-04:00,OMCL,neutral
953878.0,"Omnicell Reports Q1 EPS $0.35 vs. Est. $0.26, Rev. $171M vs. Est. $167M",2016-04-28 16:26:00-04:00,OMCL,neutral
953879.0,"Omnicell Sees FY16 Adj. EPS $1.50-$1.60 vs $1.57 Est., Sales $540M-$560M vs $572M Est.",2016-02-04 16:45:00-05:00,OMCL,neutral
953880.0,"Omnicell Sees Q1 Adj. EPS $0.25-$0.28 vs $0.33 Est., Sales $165M-$170M vs $135.5M Est.",2016-02-04 16:44:00-05:00,OMCL,neutral
953882.0,Benzinga's Top Initiations,2016-01-07 09:37:00-05:00,OMCL,positive
953883.0,"Benchmark Initiates Coverage on Omnicell at Buy, Announces $33.00 PT",2016-01-07 08:07:00-05:00,OMCL,neutral
953884.0,"Omnicell Announces Expiration of Hart-Scott-Rodino Waiting Period, Deal Expected To Close Q1 FY16",2015-12-10 09:05:00-05:00,OMCL,neutral
953885.0,Omnicell To Acquire Aesynt For $275M,2015-10-29 16:35:00-04:00,OMCL,neutral
953886.0,"Omnicell Reports Q3 Adj. EPS $0.36, Inline, Sales $125.2M vs $128.5M Est.",2015-10-29 16:30:00-04:00,OMCL,neutral
953887.0,Omnicell Appoints Peter Kuipers as CFO,2015-08-20 08:31:00-04:00,OMCL,neutral
953888.0,Omnicell Names Peter Kuipers CFO,2015-08-20 08:30:00-04:00,OMCL,neutral
953889.0,"Omnicell Reports Q2 EPS $0.24 vs. Est. $0.32, Rev. $112.8M vs. Est. $121.35M",2015-07-30 16:03:00-04:00,OMCL,neutral
953890.0,Healthcare IT Investors: Oppenheimer Just Made Some Waves,2015-06-18 12:40:00-04:00,OMCL,neutral
953891.0,Benzinga's Top Initiations,2015-06-18 09:14:00-04:00,OMCL,positive
953892.0,Oppenheimer Initiates Omnicell With Outperform,2015-06-18 08:39:00-04:00,OMCL,neutral
953893.0,"Oppenheimer Initiates Coverage on Omnicell at Outperform, Announces $44.00 PT",2015-06-18 07:06:00-04:00,OMCL,neutral
953894.0,"Omnicell Reports Q1 EPS $0.29 Vs Est $0.23, Sales $116.2M Vs Est $112.01M",2015-04-30 16:19:00-04:00,OMCL,neutral
953895.0,Omnicell Announces Has Regained NASDAQ Listing Compliance,2015-04-01 08:01:00-04:00,OMCL,neutral
953896.0,"Omnicell Reports Conclusion of Whistleblower Probe, Files '14 10-K",2015-03-31 08:02:00-04:00,OMCL,neutral
953897.0,Omnicell Receives NASDAQ Notification Of Noncompliance,2015-03-24 17:16:00-04:00,OMCL,neutral
953898.0,Omnicell Offers Update on Form 10-K Filing: Says Internal Investigation Will Not Be Closed in Time for Filing; Reaffirms FY15 Outlook,2015-03-17 16:31:00-04:00,OMCL,neutral
953899.0,Omnicell to Acquire MACH4 Pharma Systems,2015-02-26 20:19:00-05:00,OMCL,neutral
953900.0,"Omnicell Reports Q4 Adj. EPS $0.39 vs $0.33 Est., Sales $121.5M vs $114.5M Est.",2015-02-03 16:02:00-05:00,OMCL,neutral
953901.0,Omnicell to Supply Medication Automation to Major U.S. Cancer Center,2015-01-26 08:15:00-05:00,OMCL,negative
953902.0,"Omnicell, Pocket Nurse to Provide Medication Automation To Nursing Education Market",2015-01-14 10:55:00-05:00,OMCL,neutral
953903.0,"Omnicell Boosts Buyback Up To $50M, Enters Credit Agreement",2014-11-07 16:22:00-05:00,OMCL,positive
953904.0,"Omnicell, Inc. Sees FY2014 EPS $1.21-1.24 vs $1.23 Est; Sees Sales $430.0M-435.0M",2014-10-30 16:49:00-04:00,OMCL,neutral
953905.0,"Omnicell, Inc. Reports Q3 EPS of $0.30 vs $0.31 Est; Revenue of $112.54M vs $106.09M Est",2014-10-30 16:26:00-04:00,OMCL,neutral
953906.0,Wake Forest Baptist Medical Center Will Convert To Omnicell Medication Automation Solutions,2014-10-27 08:08:00-04:00,OMCL,positive
953907.0,Top 4 NASDAQ Stocks In The Healthcare Information Services Industry With The Highest Profit Margin,2014-08-28 04:32:00-04:00,OMCL,positive
953908.0,UPDATE: Omnicell Guidance Boost Related to Closing of UK-Based Surgichem Limited,2014-08-25 08:04:00-04:00,OMCL,positive
953909.0,"Omnicell, Inc. Raises FY2014 EPS Guidance from $1.17-1.23 to $1.18-1.24 vs $1.23 Est; Raises FY2014 Sales Guidance from $415.0M-425.0M to $420.0M-430.0M vs $425.0M Est",2014-08-25 08:04:00-04:00,OMCL,neutral
953910.0,"Omnicell, Inc. Reports Q2 EPS of $0.30 vs $0.29 Est; Revenue of $105.10M vs $103.23M Est",2014-07-31 17:13:00-04:00,OMCL,neutral
953911.0,"Omnicell Announces Q2 Revenue $105.1M, EPS $0.30",2014-07-31 16:39:00-04:00,OMCL,neutral
953912.0,Top 4 NASDAQ Stocks In The CATV Systems Industry With The Highest EPS,2014-07-01 04:37:00-04:00,OMCL,positive
953913.0,Top 4 NASDAQ Stocks In The Healthcare Information Services Industry With The Highest ROA,2014-06-06 05:14:00-04:00,OMCL,positive
953914.0,Top 4 NASDAQ Stocks In The Healthcare Information Services Industry With The Highest ROE ,2014-05-23 04:42:00-04:00,OMCL,positive
953915.0,Top 4 NASDAQ Stocks In The Healthcare Information Services Industry With The Lowest PEG Ratio,2014-05-06 05:06:00-04:00,OMCL,negative
953916.0,"Omnicell, Inc. Reports Q1 EPS of $0.26 vs $0.24 Est; Revenue of $101.80M vs $97.49M Est",2014-05-01 16:13:00-04:00,OMCL,neutral
953917.0,Top 4 NASDAQ Stocks In The Healthcare Information Services Industry With The Highest EPS,2014-04-30 08:58:00-04:00,OMCL,positive
953918.0,"Craig-Hallum Upgrades Omnicell, Inc. to Buy, Raises PT to $33.00",2014-04-09 09:16:00-04:00,OMCL,neutral
953919.0,Top 4 NASDAQ Stocks In The Healthcare Information Services Industry With The Lowest PEG Ratio,2014-04-08 05:23:00-04:00,OMCL,negative
953920.0,Stocks Hitting 52-Week Highs,2014-02-05 10:08:00-05:00,OMCL,neutral
953921.0,Top 4 Stocks In The Computer Based Systems Industry With The Highest Cash,2013-12-30 06:11:00-05:00,OMCL,positive
953922.0,Omnicell Signs Agreement with Bupa Care Homes to Acquire UK-Based SurgiChem Limited; Terms Undisclosed,2013-12-09 08:04:00-05:00,OMCL,positive
953923.0,Top 4 Stocks In The Computer Based Systems Industry With The Highest Revenue,2013-11-25 04:11:00-05:00,OMCL,positive
953924.0,"Omnicell, Inc. Reports Q3 EPS of $0.31 vs $0.28 Est; Revenue of $94.0M vs $94.96M Est",2013-10-31 16:03:00-04:00,OMCL,neutral
953925.0,"B. Riley & Co. Downgrades Omnicell, Inc. to Neutral, Maintains $26.00 PT",2013-09-26 08:28:00-04:00,OMCL,neutral
953926.0,"Omnicell Shares Slightly Lower Despite New Buy Rating, $29 Target from Alere Financial",2013-09-23 12:11:00-04:00,OMCL,positive
953927.0,Top 4 Stocks In The Computer Based Systems Industry With The Highest EPS Estimates,2013-08-27 04:14:00-04:00,OMCL,positive
953928.0,"Omnicell, Inc. Reports Q2 EPS of $0.27 vs $0.25 Est; Revenue of $93.69M vs $92.42M Est",2013-08-01 16:38:00-04:00,OMCL,neutral
953929.0,Invuity Elects Randall A. Lipps to the Board of Directors,2013-07-02 08:05:00-04:00,OMCL,neutral
953930.0,"Omnicell, Inc. Reports Q1 EPS of $0.21 vs $0.19 Est; Revenue of $87.10M vs $87.20M Est",2013-05-02 16:40:00-04:00,OMCL,neutral
953931.0,Omnicell Confirms Contract in 8-K Filing ,2013-03-11 13:53:00-04:00,OMCL,neutral
953932.0,Benzinga's Volume Movers,2013-03-11 11:31:00-04:00,OMCL,neutral
953933.0,Benzinga's Top Initiations,2013-02-21 08:14:00-05:00,OMCL,positive
953934.0,"Omnicell, Inc. Reports Q4 EPS of $0.25, Inline; Revenue of $90.20M vs $87.10M Est",2013-01-31 16:02:00-05:00,OMCL,neutral
953935.0,Benzinga's Top Initiations,2013-01-25 08:43:00-05:00,OMCL,positive
953936.0,UPDATE: Benchmark Initiates Omnicell at Buy on Growth and Earnings Visibility,2013-01-25 07:45:00-05:00,OMCL,positive
953937.0,"Benchmark Initiates Coverage on Omnicell, Inc. at Buy, Announces $19.00 PT",2013-01-25 07:05:00-05:00,OMCL,neutral
953938.0,Benzinga's Top Initiations,2012-12-19 07:36:00-05:00,OMCL,positive
953939.0,Omnicell Reports Q3 EPS $0.29 vs $0.22 Est; Revenues $84.33M vs $85.71M Est,2012-10-25 17:48:00-04:00,OMCL,neutral
953940.0,Omnicell Reports Q2 EPS $0.20 vs $0.18 Est; Revenues $75.4M vs $73.98M Est,2012-08-01 08:16:00-04:00,OMCL,neutral
953941.0,Omnicell Reports Q2 EPS $0.04 vs $0.06 Est; Revenues $75.4M vs $73.98M Est,2012-08-01 08:16:00-04:00,OMCL,neutral
953942.0, Omnicell G4 Solutions Selected by University of South Alabama Health System,2012-07-27 08:04:00-04:00,OMCL,positive
953943.0,Top 4 Small-Cap Stocks In The Computer Based Systems Industry With The Highest EPS Estimates,2012-06-29 02:10:00-04:00,OMCL,positive
953944.0,UPDATE: Piper Jaffray Lowers PT on Omnicell,2012-06-13 10:20:00-04:00,OMCL,negative
953945.0,Omnicell Sees 2012 Non-GAAP EPS $0.75-0.81 vs $0.71 Est; Revenues $307-315M vs $273.55M Est ,2012-06-12 08:02:00-04:00,OMCL,neutral
953946.0,Omnicell Reports Q1 EPS $0.13 vs $0.13 Est; Revenues $64.1M vs $63.40M Est,2012-05-02 16:27:00-04:00,OMCL,neutral
953947.0,Omnicell to Acquire MTS Medication Technologies for $156M ,2012-05-02 16:15:00-04:00,OMCL,neutral
953948.0,Top 4 Stocks In The Computer Based Systems Industry With The Highest Revenue,2012-04-02 03:12:00-04:00,OMCL,positive
953949.0,Top 4 Stocks In The Computer Based Systems Industry With The Highest Cash,2012-03-26 05:01:00-04:00,OMCL,positive
953950.0,Piper Jaffray Lowers PT on Omnicell to $18,2012-01-27 08:06:00-05:00,OMCL,negative
953951.0,Omnicell Reports Q4 EPS $0.19 vs $0.16 Est; Revenues $62.9M vs $63.15M Est	 			,2012-01-26 16:09:00-05:00,OMCL,neutral
953952.0,Top 4 Stocks In The Computer Based Systems Industry With The Highest ROE,2012-01-13 03:53:00-05:00,OMCL,positive
953953.0,Top 4 Stocks In The Computer Based Systems Industry With The Highest ROE,2012-01-13 03:52:00-05:00,OMCL,positive
953954.0,Weekly Homework: In Search Of The Santa Claus Rally (w/ Economic Calendar & Stock Radar),2011-12-11 23:22:00-05:00,OMCL,neutral
953955.0,"Auriga Reiterates Buy, $20 PT On Omnicell",2011-12-08 13:24:00-05:00,OMCL,neutral
953956.0,"Auriga Reiterates Buy, $20 Target on Omnicell ",2011-11-29 07:35:00-05:00,OMCL,neutral
953957.0,Disclosure Insight Maintains Medium Risk Rating on Omnicell ,2011-11-29 07:02:00-05:00,OMCL,negative
953958.0,Piper Jaffray Overweight on Omnicell,2011-10-28 08:07:00-04:00,OMCL,negative
953959.0,"Auriga Raises PT On Omnicell from $19 to $20, Maintains Buy",2011-10-28 06:22:00-04:00,OMCL,neutral
953960.0,Omnicell Reports Q3 EPS $0.16 vs $0.15 Est; Revenues $64.4M vs $62.50M Est			,2011-10-27 16:21:00-04:00,OMCL,neutral
953961.0,Top Performing Industries For September 21,2011-09-21 10:01:00-04:00,OMCL,positive
953962.0, Omnicell Renews Medication and Supply Automation Agreement with the Premier                              Healthcare Alliance,2011-08-23 08:03:00-04:00,OMCL,positive
953963.0,Omnicell Reports Q2 EPS $0.15 vs $0.13 Est; Revenues $61M vs $59.87M Est			,2011-07-28 16:17:00-04:00,OMCL,neutral
953964.0,Piper Jaffray Changes PT Of OMCL,2011-07-27 09:48:00-04:00,OMCL,neutral
953965.0,Piper Jaffray Raises PT on Omicell To $19,2011-07-27 06:40:00-04:00,OMCL,neutral
953966.0,"Stifel Nicolaus Upgrades Omnicell To Buy, $17 PT",2011-06-14 08:01:00-04:00,OMCL,neutral
953967.0,Piper Jaffray Reiterates Overweight on Omnicell,2011-06-14 07:18:00-04:00,OMCL,negative
953968.0,Auriga Reiterates Buy Rating On Omnicell,2011-06-01 07:35:00-04:00,OMCL,neutral
953969.0,Piper Jaffray Maintains Overweight Rating And PT At $17 On Omnicell (OMCL),2011-05-03 06:39:00-04:00,OMCL,negative
953970.0,Omnicell Reports EPS of $0.11 vs. $0.10 Estimate; Revenues $57.2M vs. $57.72M Estimate ,2011-05-02 16:16:00-04:00,OMCL,neutral
953971.0,Piper Jaffray Reiterates Overweight Rating On OMCL,2011-03-23 08:25:00-04:00,OMCL,negative
953972.0,Omnicell Fails to Meet Estimates - Analyst Blog,2011-01-31 12:01:00-05:00,OMCL,negative
953973.0,Omnicell Fails to Meet Estimates - Analyst Blog,2011-01-31 11:15:00-05:00,OMCL,negative
953974.0,"Piper Jaffray Maintains OW Rating, $17 PT On OMCL ",2011-01-28 09:53:00-05:00,OMCL,neutral
953975.0,Omnicell Beats by a Penny - Analyst Blog,2010-10-28 18:33:00-04:00,OMCL,neutral
953976.0,"FBR Capital Changes SYMC, AKAM, PNR, OMCL And NARA Price Targets",2010-10-28 12:55:00-04:00,OMCL,neutral
953977.0,Cerner and Omnicell Ratings Maintained Following Healthcare Conference,2010-10-13 08:15:00-04:00,OMCL,neutral
953978.0,Increased Price Target For Omnicell,2010-10-06 10:55:00-04:00,OMCL,positive
953979.0,"Auriga USA Reiterates Buy Rating On PCS, OMCL",2010-10-06 10:38:00-04:00,OMCL,neutral
953980.0,Omnicell Announces Acquisition of Pandora Data Systems,2010-10-05 08:06:00-04:00,OMCL,neutral
953981.0,Piper Jaffray's Field Trip To Sharp Healthcare,2010-09-24 08:01:00-04:00,OMCL,neutral
953982.0,Omnicell Deemed Best-in-Class by Wellmont Health System,2010-08-17 08:44:00-04:00,OMCL,neutral
953983.0,Partnership Deal for Omnicell - Analyst Blog,2010-08-11 19:14:00-04:00,OMCL,neutral
953984.0,"Company News for June 10, 2010 - Corporate Summary",2010-06-10 10:04:00-04:00,OMCL,neutral
953985.0,Auriga Upgrades Omnicell to Buy (OMCL),2010-06-10 09:04:00-04:00,OMCL,neutral
953986.0,"Benzinga’s Top Upgrades (UTHR, MBT, CHRW, OMCL)",2010-06-10 08:06:00-04:00,OMCL,positive
953987.0,Auriga Upgrades OMCL To Buy,2010-06-10 06:32:00-04:00,OMCL,neutral
953988.0,Omnicell Q1 Results May Be Largely Inline,2010-04-21 15:39:00-04:00,OMCL,neutral
953989.0,Omnicell Inc. (OMCL) Q4 Review,2010-01-29 12:46:00-05:00,OMCL,neutral
